Non-activatable mutant of inhibitor of kappa B kinase α (IKKα) exerts vascular site-specific effects on atherosclerosis in Apoe-deficient mice

Pathricia Tilstam (1) , Josefin Soppert (2) , Christian Hemmers (2) , Eva Harlacher (2) , Yvonne Döring (3) , Emiel P.C. van Der Vorst (3, 1) , Corinna Schulte (2) , Setareh Alampour-Rajabi (2) , Wendy Theelen (2) , Yaw Asare (1) , Menno P.J. de Winther (3, 4) , Toby Lawrence (5) , Jürgen Bernhagen (6) , Andreas Schober (3) , Alma Zernecke (7) , Joachim Jankowski (1) , Christian Weber (3, 8, 9) , Heidi Noels (1)

1 UKA - Universitätsklinikum RWTH Aachen - University Hospital Aachen [Aachen, Germany]
2 YSM - Yale School of Medicine [New Haven, Connecticut]
3 Institute for Cardiovascular Prevention (IPEK)
4 UvA - University of Amsterdam [Amsterdam]
5 CIML - Centre d'Immunologie de Marseille - Luminy
6 ISD - Institute for Stroke and Dementia Research
7 University Hospital of Würzburg
8 German Centre for Cardiovascular Research (DZHK) partner site Berlin
9 CARIM - Cardiovascular Research Institute Maastricht

Domains: Life Sciences [q-bio]

Pathricia Tilstam, Josefin Soppert, Christian Hemmers, Eva Harlacher, Yvonne Döring, et al.. Non-activatable mutant of inhibitor of kappa B kinase α (IKKα) exerts vascular site-specific effects on atherosclerosis in Apoe-deficient mice. Atherosclerosis, 2020, 292, pp.23-30. ⟨10.1016/j.atherosclerosis.2019.10.023⟩. ⟨hal-02998565⟩